Prevalence and Indicators of Viral Suppression Among Persons With Diagnosed HIV Infection Retained in Care -- Georgia, 2010

< Prev | 1 | 2 | 3

*TABLE 1. Prevalence of Viral Suppression Among Persons Aged ≥13 Years Who Had HIV Infection Diagnosed in 2010 and Were Retained in Care (N = 1,340), by Selected Characteristics -- Georgia**^†
Characteristic	Persons with diagnosed HIV		Viral suppression
Characteristic	No.	%	No.	%
Overall	1,340	100.0	958	71.5
Race/Ethnicity
Black	720	53.7	456	63.3
White	149	11.1	116	78.2
Hispanic	78	5.8	61	77.9
Other/Unknown	393	29.3	325	82.7
Age group (yrs)^§
13-24	255	19.0	144	56.5
25-34	366	27.3	258	70.5
35-44	307	22.9	229	74.6
45-54	290	21.6	228	78.6
≥55	122	9.0	99	81.2
Disease stage at diagnosis^¶
1	211	15.8	136	64.5
2	336	25.1	243	72.3
3	375	28.0	302	80.5
Unknown	418	31.2	277	66.3
Transmission category**
Male	1,033	77.1 (100.0)	740	71.6
Male-to-male sexual contact	638	47.6 (61.7)	418	65.5
Injection drug use	30	2.3 (3.0)	20	65.3
Male-to-male sexual contact and injection drug use	15	1.1 (1.5)	10	66.7
Heterosexual contact	46	3.4 (4.4)	35	77.4
Other/Unknown^††	304	22.7 (29.4)	257	84.5
Female	307	22.9 (100.0)	218	71.0
Injection drug use	43	3.2 (13.4)	33	78.6
Heterosexual contact	208	15.6 (67.9)	142	67.9
Other/Unknown^††	56	4.2 (18.3)	43	76.8
* Retained in care defined as having at least two laboratory tests (CD4+ or viral load) at least 3 months apart during 4-15 months after diagnosis. † Among persons residing in Georgia and having a positive Western Blot or viral load based on surveillance data reported during 2010. Viral suppression defined as viral load <200 on the basis of most recent test during 4-15 months after diagnosis. Only includes persons with their sex recorded at birth. § Age based on the person's age at year's end 2010. ¶ Based on first recorded CD4+ cell count ≤3 months after diagnosis. Defined as stage 1: CD4+ count ≥500 cells/µL or CD4+ percentage of total lymphocytes ≥29; stage 2: CD4+ count of 200-499 cells/µL or CD4+ percentage of total lymphocytes of 14-28; and stage 3: CD4+ count of <200 cells/µL or CD4+ percentage of total lymphocytes of <14. ** Data by transmission category have been statistically adjusted to account for missing transmission category. Nested percentages indicate percentages among newly diagnosed persons of specified sex. †† Includes hemophilia, blood transfusion, perinatal exposure, or risk factor unknown or not indicated.

*TABLE 2. Indicators of Viral Suppression Among Persons Aged ≥13 Years Who Had HIV Infection Diagnosed in 2010 and Were Retained in Care (N = 1,340), by Selected Characteristics -- Georgia**^†
Characteristic	Prevalence ratio	(95% CI)	p value
Race/Ethnicity
Black	0.9	(0.8-0.9)	<0.01
White (reference group)	1.0
Hispanic	1.0	(0.9-1.2)	0.70
Other/Unknown	1.1	(1.0-1.2)	0.07
Age group (yrs)^§
13-24	0.8	(0.7-0.9)	<0.01
25-34	0.9	(0.7-1.0)	0.17
35-44	0.9	(0.8-1.0)	0.23
45-54	0.9	(0.9-1.1)	0.33
≥55 (reference group)	1.0
Disease stage at diagnosis^¶
1	0.8	(0.7-0.9)	<0.01
2	0.9	(0.8-1.0)	0.02
3 (reference group)	1.0
Unknown	0.8	(0.8-0.9)	<0.01
Sex
Male	1.0
Female	1.0	(0.9-1.1)	0.97
Abbreviation: CI = confidence interval. * Retained in care defined as having at least two laboratory tests (CD4+ or viral load) at least 3 months apart during 4-15 months after diagnosis. † Among persons residing in Georgia and having a positive Western Blot or viral load based on surveillance data reported during 2010. Viral suppression defined as viral load <200 on the basis of most recent test during 4-15 months after diagnosis. Only includes persons with their sex recorded at birth. § Age based on the person's age at year's end 2010. ¶ Based on first recorded CD4+ cell count ≤3 months after diagnosis. Defined as stage 1: CD4+ count ≥500 cells/µL or CD4+ percentage of total lymphocytes ≥29; stage 2: CD4+ count of 200-499 cells/µL or CD4+ percentage of total lymphocytes of 14-28; and stage 3: CD4+ count of <200 cells/µL or CD4+ percentage of total lymphocytes of <14.

< Prev | 1 | 2 | 3